Karyopharm Therapeutics financial statements

카료팜 테라퓨틱스NASDAQ:KPTI · Nasdaq · Healthcare · sector #13
$0.6705-16.42%
2026-10-05 close

Karyopharm Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $145M. 2024 operating profit was −$75M.

Reported results

Karyopharm Therapeutics notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q